LY-2584702,1082949-67-4

LY-2584702,1082949-67-4

收藏
  • 询价
  • MedChemExpress(MCE)已认证
  • 美国
  • HY-12493
  • 2025年12月05日
    avatar
    品牌商
    13钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 保存条件

      Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.

    • 库存

      货期:询盘

    • 供应商

      MedChemExpress LLC

    • CAS号

      1082949-67-4

    • 规格

      询盘

    MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

    LY-2584702 free base

    CAS No. : 1082949-67-4

    MCE 国际站:LY-2584702 free base

    产品活性:LY-2584702 free base 是一种 ATP 竞争性的选择性 p70S6K 抑制剂,IC50 为 4 nM。LY-2584702 抑制 S6K1IC50 为 2 nM。

    研究领域:MAPK/ERK Pathway

    作用靶点:Ribosomal S6 Kinase (RSK)

    In Vitro: LY-2584702 (LY2584702) inhibits phosphorylation of the S6 ribosomal protein (pS6) in HCT116 colon cancer cells with an IC50 of 0.1-0.24 μM. For pS6 inhibition in cells, the IC50=100 nM. LY-2584702 has some activity against the S6K-related kinases MSK2 and RSK at high concentrations (enzyme assay IC50=58-176 nM). LY-2584702 inhibits S6K activity in EOMA cells, as determined by the phosphorylation of its downstream effector S6, in a dose-dependent manner. Proliferation of A549 is significantly inhibited by LY-2584702 (LY2584702) treating over 24 h at 0.1 μM (P<0.05); and the trend of decline is more conspicuous with longer treatment and/or with the increased drug concentration (all P<0.05). Similar results are also observed in SK-MES-1, although the obvious inhibition is led by LY-2584702 at 0.6 μM (P<0.05), much higher than that of A549.

    In Vivo: LY-2584702 demonstrates significant single-agent efficacy in both U87MG glioblastoma and HCT116 colon carcinoma xenograft models at two dose levels of 2.5 mg/kg twice daily (BID) and 12.5 mg/kg BID. LY-2584702 demonstrates statistically significant tumour growth reduction at TMED50 (threshold minimum effective dose 50%) (2.3 mg/kg) and TMED90 (10 mg/kg) in the HCT116 colon carcinoma xenograft model. To examine the role of S6K in vivo, EOMA cells expressing shAkt3 are implanted in nu/nu mice, then treated for 14 days with LY-2584702 or Rapamycin. Analysis of tumors removed after 14 days shows that LY-2584702 inhibits S6 phosphorylation almost as effectively as Rapamycin. Loss of Akt3 increases tumor growth as compared with pLKO. LY-2584702 treatment alone does not significantly affect the growth of pLKO tumors. However, LY-2584702 significantly reduces the growth of tumors with shAkt3.

    相关产品:BI-D1870  |  PF-4708671  |  Carnosol  |  Quercitrin  |  LJH685  |  LY-2584702 tosylate salt  |  SM1-71  |  AT13148  |  SL 0101-1  |  Sodium Salicylate  |  Pluripotin  |  AT7867  |  CKI-7 free base  |  FMK  |  M2698  |  LJI308  |  AD80  |  BIX 02565  |  GSK-25  |  BRD7389  |  Eudesmin  |  S6K1-IN-1  |  AD57  |  Bisindolylmaleimide V  |  Coronarin A  |  DD1

    热门产品线:重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

    Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

    类药多样性化合物库
    顾客使用MCE产品发表的科研文献
    一站式药筛新体验
    MCE 您身边的生物活性分子大师 | 抑制剂、激动剂、化合物库
    重组蛋白 | 高纯度、高稳定性
    磁珠
    MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1164
    爱必信(上海)生物科技有限公司
    2025年06月25日询价
    ¥329
    MedChemExpress LLC
    2025年12月05日询价
    ¥571
    广州市左克生物科技发展有限公司
    2025年12月19日询价
    ¥6000
    上海嵘崴达实业有限公司
    2025年07月31日询价
    ¥10600
    TargetMol中国
    2025年07月08日询价
    LY-2584702,1082949-67-4
    询价